← Eichor
Location: Miami Synced from ClinicalTrials.gov · July 28, 2026

Clinical studies recruiting near Miami

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Phase 3 · Investigative Site US016 · Incyte Corporation · NCT06959225
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · LCC Medical Research Institute, LLC · Hoffmann-La Roche · NCT06588855
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · Sylvester Comprehensive Cancer Center University of Miami Mi · Corvus Pharmaceuticals, Inc. · NCT06561048
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Phase 4 · University of Miami · University of Miami · NCT06412120
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · University of Miami Health System Sylvester Comprehensive Ca · New York Blood Center · NCT01656603
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in
Phase 2 · GMI Florida - Central Miami Medical Institute /ID# 267839 · AbbVie · NCT06846320
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants W
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06911112
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · University of Miami Hospital and Clinics · GOG Foundation · NCT05659381
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Med-Care Research Corp · Philip Morris Products S.A. · NCT07108166
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · Sunrise Research Institute /ID# 237382 · AbbVie · NCT03339128
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Phase 1 · University of Miami School of Medicine ( Site 0021) · Merck Sharp & Dohme LLC · NCT07199465
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · Sylvester Comprehensive Cancer Center · Pfizer · NCT05355701
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · University of Miami · Jaeb Center for Health Research · NCT06837181
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chroni
Phase 1 · Quotient Sciences Sea View · Novartis Pharmaceuticals · NCT07235059
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · University of Miami Miller School of Medicine-Sylvester Canc · National Cancer Institute (NCI) · NCT05987241
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin)
Phase 1/Phase 2 · Eisai Inc. · NCT04300556
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Coral Gables Surgery Center · Stryker Instruments · NCT03072927
VIBRANT: VIB4920 for Active Lupus Nephritis
Phase 2 · University of Miami Miller School of Medicine: Nephrology & · National Institute of Allergy and Infectious Diseases (NIAID · NCT05201469
Use of CereGate Therapy for Freezing of Gait in PD
NA · University of Miami · CereGate Inc. · NCT05292794
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Particip
Phase 1/Phase 2 · University of Miami Hospital and Clinics, Sylvester Cancer C · Merck Sharp & Dohme LLC · NCT06353386
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · Reed Medical Research · Pfizer · NCT07363694
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresen
NA · University of Miami · University of Miami · NCT06587204
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implan
NA · University of Miami · Restorear Devices LLC · NCT06375278
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Premier Clinical Research Institute · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06961214
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Miami Dermatology & Laser Research · Ipsen · NCT07435428
xDRIVE for Florida-based Cancer Patients
NA · First Ascent Biomedical · First Ascent Biomedical Inc. · NCT07167381
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · University of Miami Miller School of Medicine-Sylvester Canc · NRG Oncology · NCT04804644
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Phase 3 · University of Miami Miller School of Medicine · Eli Lilly and Company · NCT05723198
Immune Reconstitution in Stem Cell Transplant Recipients
Phase N/A · University of Miami · University of Miami · NCT02129543
Look up another city
Look up another condition

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.